#

Pharmaceutical Companies

: 92
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
Mobia Medicals development - Vivistim device for vagus nerve stimulation / Photo: Vivistim.com
News·
Mobia Medical IPO: developer of stroke rehabilitation systems goes public
Sales of Wegovy in tablets beat forecasts / Photo: JHVEPhoto / Shutterstock
News·
Sales of Novo Nordisk's obesity pill double expectations. Shares soared
Seaport Therapeutics shares become available / Photo: Seaport Therapeutics
News·
IPO of Seaport Therapeutics: shares of the antidepressant developer become available
Eli Lilly grew profits by 168% and raised its full-year forecast / Photo: Tada Images / Shutterstock
News·
Eli Lilly grew earnings 168% and raised its full-year guidance. What's up with the stock?
Boston-based biotech Avalyn Pharma develops inhaled drugs / Photo: Avalyn Pharma
News·
Avalyn Pharma IPO: Novo Nordisk-backed biotech goes public
Oil prices rose after the breakdown of the second round of talks between the US and Iran in Pakistan / Photo: The White House
Review·
Top story for the morning: US-Iran talks collapse, $12 billion deal in pharma market
Eli Lilly to buy cancer drug developer Kelonia / Photo: Jonathan Weiss / Shutterstock.com
News·
Eli Lilly to buy oncology drug developer. What is it paying up to $7 billion for?
Shares of online pharma platform operator Hims & Hers were adding about 47% on the premarket on March 9 / Photo: Photo Nature Travel / Shutterstock
News·
Shares of online pharmacy Hims & Hers soared 40% amid a general sell-off. What is it?
Pharma is the most defensive sector amid conflict in the Middle East - UBS/Photo: shutterstock.com/Jonathan Weiss
News·
'Most defensive sector': UBS names stocks that can 'safely survive war'
VolitionRx shares soar on positive news / Photo: Facebook/VolitionRx
Small Caps·
Cancer blood test maker VolitionRX soars 25% in a day on reported commercial progress
Vir Biotechnology shares jumped on the announcement of a new partnership and other news / Photo: X / Vir Biotech
Small Caps·
'Seminal moment': Biotech Vir sees shares jump over 25% amid flurry of announcements
Load more